Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

T. Zahaf · SciRah

Researcher profile · Semantic Scholar

T. Zahaf

Share profile

T. Zahaf — researcher profile on SciRah

h-index: 23
Works: 49
Citations: 8,319

Most-cited papers

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial.
D. Harper, E. Franco, C. Wheeler, D. Ferris +12 more
2004The Lancet1,638 citations
Semantic Scholar
Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women.
J. Paavonen, P. Naud, J. Salmerón, C. Wheeler +23 more
2009The Lancet1,592 citations
Semantic Scholar
Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
A. Cunningham, R. Chlibek, J. Díez-Domingo, E. Athan +14 more
2015New England Journal of Medicine1,304 citations Open access
Semantic Scholar
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Anthony L. Cunningham, Himal Lal, Martina Kovač, Roman Chlíbek +27 more
2016New England Journal of Medicine929 citations Open access
Semantic Scholar
Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial.
C. Wheeler, X. Castellsagué, Suzanne M. Garland, A. Szarewski +23 more
2012The Lancet Oncology542 citations
Semantic Scholar
Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years.
B. Romanowski, P. D. de Borba, P. Naud, C. Roteli-Martins +28 more
2009The Lancet389 citations
Semantic Scholar
Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
P. Naud, C. Roteli-Martins, N. D. de Carvalho, J. Teixeira +6 more
2014Human Vaccines & Immunotherapeutics214 citations Open access
Semantic Scholar
Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine
C. Roteli-Martins, P. Naud, P. D. de Borba, J. Teixeira +5 more
2012Human Vaccines & Immunotherapeutics196 citations Open access
Semantic Scholar
Sustained efficacy and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine up to 7.3 years in young adult women.
N. D. de Carvalho, J. Teixeira, C. Roteli-Martins, P. Naud +4 more
2010Vaccine179 citations
Semantic Scholar
Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years.
T. Schwarz, M. Spaczyński, A. Schneider, J. Wysocki +7 more
2009Vaccine166 citations
Semantic Scholar
Analysis of adverse events of potential autoimmune aetiology in a large integrated safety database of AS04 adjuvanted vaccines.
T. Verstraeten, D. Descamps, M. David, T. Zahaf +4 more
2008Vaccine164 citations
Semantic Scholar
Efficacy of the human papillomavirus (HPV)‐16/18 AS04‐adjuvanted vaccine in women aged 15–25 years with and without serological evidence of previous exposure to HPV‐16/18
A. Szarewski, W. Poppe, S. Skinner, C. Wheeler +23 more
2012International Journal of Cancer148 citations Open access
Semantic Scholar
Efficacy of Human Papillomavirus 16 and 18 (HPV-16/18) AS04-Adjuvanted Vaccine against Cervical Infection and Precancer in Young Women: Final Event-Driven Analysis of the Randomized, Double-Blind PATRICIA Trial
D. Apter, C. Wheeler, J. Paavonen, X. Castellsagué +23 more
2015Clinical and Vaccine Immunology113 citations Open access
Semantic Scholar
Long-term Protection Against Herpes Zoster by the Adjuvanted Recombinant Zoster Vaccine: Interim Efficacy, Immunogenicity, and Safety Results up to 10 Years After Initial Vaccination
A. Strezova, J. Díez-Domingo, Kamal Al Shawafi, J. Tinoco +173 more
2022Open Forum Infectious Diseases97 citations Open access
Semantic Scholar
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
C. Boutry, Andrew Hastie, J. Díez-Domingo, J. Tinoco +164 more
2021Clinical Infectious Diseases92 citations Open access
Semantic Scholar
Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials
A. F. Dagnew, D. Rausch, C. Hervé, T. Zahaf +2 more
2020Rheumatology63 citations Open access
Semantic Scholar
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials.
Marta López-Fauqued, L. Cámpora, Frédérique Delannois, M. El Idrissi +50 more
2019Vaccine60 citations Open access
Semantic Scholar
Low-field NMR water proton longitudinal relaxation in ultrahighly diluted aqueous solutions of silica-lactose prepared in glass material for pharmaceutical use
Jean-Louis Demangeat, P. Gries, B. Poitevin, J. Droesbeke +4 more
200459 citations
Semantic Scholar
Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials
L. Oostvogels, T. Heineman, Robert W. Johnson, M. Levin +19 more
2019Human Vaccines & Immunotherapeutics48 citations Open access
Semantic Scholar
Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine
T. Schwarz, M. Kocken, T. Petäjä, M. Einstein +9 more
2010Human Vaccines48 citations Open access
Semantic Scholar
Substantial impact on precancerous lesions and HPV infections through 5.5 years in women vaccinated with the HPV-16/18 L1 VLP AS04 candidate vaccine
S. Gall, J. Teixeira, C. Wheeler, P. Naud +6 more
200745 citations
Semantic Scholar
Efficacy of the adjuvanted recombinant zoster vaccine (RZV) by sex, geographic region, and geographic ancestry/ethnicity: A post-hoc analysis of the ZOE-50 and ZOE-70 randomized trials.
D. Willer, L. Oostvogels, A. Cunningham, Pierre Gervais +52 more
2019Vaccine30 citations Open access
Semantic Scholar
Immune responses elicited by a fourth dose of the HPV-16/18 AS04-adjuvanted vaccine in previously vaccinated adult women.
A. Moscicki, C. Wheeler, B. Romanowski, J. Hedrick +8 more
2012Vaccine30 citations
Semantic Scholar
Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials
R. Colindres, V. Wascotte, Alain Brecx, Christopher Clarke +7 more
2020Human Vaccines & Immunotherapeutics23 citations Open access
Semantic Scholar
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against abnormal cytology and low-grade histopathological lesions in an oncogenic HPV-naïve population
W. Tjalma, J. Paavonen, P. Naud, C. Wheeler +20 more
200923 citations
Semantic Scholar
Safety and immunogenicity of an AS01-adjuvanted varicella zoster virus subunit candidate vaccine (HZ/su)
Himal Lal, T. Zahaf, T. Heineman
2013Human Vaccines & Immunotherapeutics22 citations Open access
Semantic Scholar
Nonparametric tests of independence of two autoregressive time series based on autoregression rank scores
M. Hallin, J. Jurečková, J. Picek, T. Zahaf
199921 citations
Semantic Scholar
Computation of the exact information matrix of Gaussian dynamic regression time series models
A. Klein, G. Mélard, T. Zahaf
199815 citations Open access
Semantic Scholar
The adjuvanted recombinant zoster vaccine is efficacious and safe in Asian adults ≥ 50 years of age: a sub-cohort analysis of the ZOE-50 and ZOE-70 randomized trials
J. Kim, J. Diaz-Decaro, Ning Jiang, Shinn-Jang Hwang +16 more
2021Human Vaccines & Immunotherapeutics14 citations Open access
Semantic Scholar
Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine
A. Callegaro, W. Burny, C. Hervé, J. Kim +4 more
2021Journal of Infectious Diseases14 citations Open access
Semantic Scholar
Non‐parametric tests in AR models with applications to climatic data
M. Hallin, T. Zahaf, J. Jurečková, J. Kalvová +1 more
199711 citations
Semantic Scholar
O929 Sustained levels of total and neutralising antibodies and favourable long term safety with the HPV‐16/18 AS04‐adjuvanted vaccine (Cervarix®): Follow‐up to 7.3 years
N. D. de Carvalho, C. Roteli-Martins, José A. Teixeira, P. Naud +4 more
20098 citations
Semantic Scholar
Vaccine clinical trials with dynamic borrowing of historical controls: Two retrospective studies
A. Callegaro, Naveen Karkada, E. Aris, T. Zahaf
2023Pharmaceutical statistics7 citations Open access
Semantic Scholar
Assurance in vaccine efficacy clinical trial design based on immunological responses
A. Callegaro, T. Zahaf, F. Tibaldi
2021Biometrical journal. Biometrische Zeitschrift7 citations Open access
Semantic Scholar
Dynamic borrowing of historical controls adjusting for covariates in vaccine efficacy clinical trials
A. Callegaro, Yongyi Luo, Naveen Karkada, T. Zahaf
2024Pharmaceutical statistics6 citations Open access
Semantic Scholar
Vaccine efficacy with/without evidence of prior HPV-16/18 infection: analysis of PATRICIA, a phase III trial with AS04-adjuvanted HPV-16/18 vaccine
W. Poppe, J. Paavonen, P. Naud, J. Salmerón +20 more
20094 citations
Semantic Scholar
2779. Efficacy of the Adjuvanted Recombinant Zoster Vaccine According to Sex, Geographic Region, and Geographic Ancestry/Ethnicity: A Post-hoc Analysis
D. Willer, V. Wascotte, J. Kim, T. Zahaf +8 more
2019Open Forum Infectious Diseases2 citations Open access
Semantic Scholar
Erratum: Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: A randomised controlled trial (Obstetrical and Gynecological Survey (March 2005) 60 (171-173))
D. M. Harper, E. Franco, C. Wheeler, D. Ferris +12 more
20052 citations
Semantic Scholar
A program for computing the exact Fisher information matrix of a Gaussian VARMA model
A. Klein, G. Mélard, J. Niemczyk, T. Zahaf
20042 citations
Semantic Scholar
Implementation of the ICH E9 (R1) addendum in vaccine efficacy studies: the hypothetical and principal stratum strategies
Silvia Noirjean, D. Bottigliengo, Elisa Cinconze, Ali Charkhi +3 more
2025Journal of Biopharmaceutical Statistics1 citations Open access
Semantic Scholar
2780. Reactogenicity Profile of Adjuvanted Recombinant Zoster Vaccine after Dose 2 According to the Intensity of the Same Event Experienced after Dose 1
R. Colindres, V. Wascotte, Alain Brecx, Christopher Clarke +7 more
2019Open Forum Infectious Diseases1 citations Open access
Semantic Scholar
Statistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development
A. Callegaro, M. Kassapian, T. Zahaf, F. Tibaldi
2016Statistical Methods in Medical Research1 citations
Semantic Scholar
Cross-protective efficacy of the AS04-adjuvanted HPV-16/18 vaccine in oncogenic HPV infection-naïve women: results from a double-blind, randomised, phase III trial (PATRICIA)
H. Kitchener, J. Paavonen, P. Naud, J. Salmerón +21 more
20091 citations
Semantic Scholar
Efficacy of the HPV-16/18 AS04-adjuvanted vaccine against abnormal cytology and reduction in colposcopy referrals and cervical excisions in an HPV-negative population
Song-Nan Chow, J. Paavonen, P. Naud, C. Wheeler +18 more
20091 citations
Semantic Scholar
Nonparametric AR order identification with application to climatic data
M. Hallin, J. Jurečková, J. Kalvová, J. Picek +1 more
19971 citations
Semantic Scholar
26. Is There a Correlation Between Reactogenicity and Immune Responses of the Adjuvanted Recombinant Zoster Vaccine (RZV)? A Post-hoc Analysis
A. Callegaro, D. Willer, W. Burny, C. Hervé +5 more
2021Open Forum Infectious Diseases0 citations Open access
Semantic Scholar
Reactogenicity of an adjuvanted herpes zoster subunit vaccine in older adults: results of the phase 3 ZOE-50 trial
T. Vesikari, A. Cunningham, O. Godeaux, Anitta Ahonen +15 more
20150 citations Open access
Semantic Scholar
ustained efficacy and immunogenicity of the HPV-16 / 18 AS 04-adjuvanted accine up to 7 . 3 years in young adult women
D. Carvalhoa, J. Teixeirab, C. M. Roteli-Martinsc, P. Naudd +4 more
20100 citations
Semantic Scholar
Nonparametric tests of independence between two autoregressive series based on autoregression rank scores
M. Hallin, J. Jurečková, J. Picek, T. Zahaf
19990 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Naud×16
Invite
P. Naud — researcher profile on SciRah
A. Schuind×15
Invite
A. Schuind — researcher profile on SciRah
G. Dubin×14
Invite
G. Dubin — researcher profile on SciRah
D. Descamps×14
Invite
D. Descamps — researcher profile on SciRah

×13

Invite

A. Cunningham — researcher profile on SciRah

Invite

C. Wheeler — researcher profile on SciRah

Invite

T. Schwarz — researcher profile on SciRah

Invite

K. Hardt — researcher profile on SciRah

J. Teixeira×10

Invite

J. Teixeira — researcher profile on SciRah

B. Romanowski×10

Invite

B. Romanowski — researcher profile on SciRah

Invite

M. Levin — researcher profile on SciRah

Invite

J. Paavonen — researcher profile on SciRah